COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices
Abstract
:1. Introduction
2. Materials and Methods
2.1. Survey Structure
2.2. Statistical Analysis
2.3. Open-Ended Responses
3. Results
3.1. Descriptive Statistics
- Mean (SD): 63.7 (16.2)
- Median (Min, Max): 65.0 (20.0–100.0)
3.2. Multi-Variable Regression
3.3. Open-Ended Comments
4. Discussion
Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- World Health Organization. Coronavirus -COVID-19-Dashboard. 2022. Available online: https://covid19.who.int/ (accessed on 6 August 2022).
- Cavanna, L.; Citterio, C.; Toscani, I. COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis. Vaccines 2021, 9, 1048. [Google Scholar] [CrossRef] [PubMed]
- Kirtane, K.; Geiss, C.; Arredondo, B.; Hoogland, A.I.; Chung, C.H.; Muzaffar, J.; Patel, K.B.; Gonzalez, B.D.; Jim, H.S.; Oswald, L.B. “I have cancer during COVID; that’s a special category”: A qualitative study of head and neck cancer patient and provider experiences during the COVID-19 pandemic. Support Care Cancer 2022, 30, 4337–4344. [Google Scholar] [CrossRef] [PubMed]
- Erdem, D.; Karaman, I. Awareness and perceptions related to COVID-19 among cancer patients: A survey in oncology department. Eur. J. Cancer Care 2020, 29, e13309. [Google Scholar] [CrossRef]
- Ciążyńska, M.; Pabianek, M.; Szczepaniak, K.; Ułańska, M.; Skibińska, M.; Owczarek, W.; Narbutt, J.; Lesiak, A. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psychooncology 2020, 29, 1377–1379. [Google Scholar] [CrossRef] [PubMed]
- Zuliani, S.; Zampiva, I.; Tregnago, D.; Casali, M.; Cavaliere, A.; Fumagalli, A.; Merler, S.; Riva, S.T.; Rossi, A.; Zacchi, F.; et al. Organisational challenges, volumes of oncological activity and patients’ perception during the severe acute respiratory syndrome coronavirus 2 epidemic. Eur. J. Cancer. 2020, 135, 159–169. [Google Scholar] [CrossRef]
- Cheli, S.; Lam, W.; Estapé, T.; Winterling, J.; Bahcivan, O.; Andritsch, E.; Weis, J.; Centeno, I.; Serpentini, S.; Farkas, C.; et al. Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients. Psycho-Oncology 2022, 31, 46–53. [Google Scholar] [CrossRef]
- Ugas, M.A.; Samoil, D.; Avery, L.; Berlin, A.; Giuliani, M.E.; Papadakos, T.J.; Quartey, N.K.; Papadakos, J.K. COVID-19 and patients with cancer: Investigating treatment impact, information sources, and COVID-19-related knowledge, attitudes, and practices. Cancer 2022, 128, 746–761. [Google Scholar] [CrossRef]
- Limesurvey GmbH./LimeSurvey: An Open Source Survey Tool/LimeSurvey GmbH, Hamburg, Germany. Available online: http://www.limesurvey.org (accessed on 6 August 2022).
- Chew, L.D.; Bradley, K.A.; Boyko, E.J. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004, 36, 588–594. [Google Scholar]
- Vaccine Confidence and Survey Question Bank. Centers for Disease Control and Prevention. 2021. Available online: https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence/rca-guide/downloads/CDC_RCA_Guide_2021_Tools_AppendixD_Surveys-508.pdf (accessed on 6 August 2022).
- Harrell, F.E., Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis; Springer: New York, NY, USA, 2015; p. 337. [Google Scholar]
- QSR International Pty Ltd. NVivo (released in March 2020). 2020. Available online: https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home (accessed on 6 August 2022).
- Detsky, A.S.; Bogoch, I.I. COVID-19 in Canada: Experience and Response to Waves 2 and 3. JAMA 2021, 326, 1145–1146. [Google Scholar] [CrossRef]
- Karaivanov, A.; Kim, D.; Lu, S.E.; Shigeoka, H. COVID-19 vaccination mandates and vaccine. Nat. Hum. Behav. 2022. [Google Scholar] [CrossRef]
- Fraser, A.; McNeill, R.; Robinson, J. Cancer care in a time of COVID: Lung cancer patient’s experience of telehealth and connectedness. Support Care Cancer 2022, 30, 1823–1830. [Google Scholar] [CrossRef]
- Berlin, A.; Lovas, M.; Truong, T.; Melwani, S.; Liu, J.; Liu, Z.A.; Badzynski, A.; Carpenter, M.B.; Virtanen, C.; Morley, L.; et al. Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19. JAMA Oncol. 2021, 7, 597–602. [Google Scholar] [CrossRef] [PubMed]
- Su, Z.; McDonnell, D.; Ahmad, J.; Cheshmehzangi, A.; Xiang, Y.T. Mind the “worry fatigue” amid Omicron scares. Brain Behav. Immun. 2022, 101, 60–61. [Google Scholar] [CrossRef] [PubMed]
- Bhuiya, T.; Klares, I.I.I.R.; Conte, M.A.; Cervia, J.S. Predictors of misperceptions, risk perceptions, and personal risk perceptions about COVID-19 by country, education and income. J. Investig. Med. 2021, 69, 1473–1478. [Google Scholar] [CrossRef]
- Price, D.M.; Gesselman, A.N.; Fikslin, R.A.; Goldberg, A.J.; Pervez, O.; Reinka, M.A.; Franklin, E. How Can I Get COVID?: Understanding Differences in American Heterosexual and Sexual Minority Men’s Risk Perception. Arch. Sex. Behav. 2022, 51, 203–216. [Google Scholar] [CrossRef] [PubMed]
- Yan, A.P.; Howden, K.; Mahar, A.L.; Glidden, C.; Garland, S.N.; Oberoi, S. Gender differences in adherence to COVID-19 preventative measures and preferred sources of COVID-19 information among adolescents and young adults with cancer. Cancer Epidemiol. 2022, 77, 102098. [Google Scholar] [CrossRef] [PubMed]
- McKenzie, K. Socio-demographic data collection and equity in COVID-19 in Toronto. eClinicalMedicine 2021, 34, 100812. [Google Scholar] [CrossRef] [PubMed]
- Lu, C.; Tago, A.; Olaiya, O.; Verhovsek, M. Race-based data collection among COVID-19 inpatients: A retrospective chart review. Healthc. Manag. Forum 2022, 35, 130–134. [Google Scholar] [CrossRef] [PubMed]
- King, J.; Ferraz, O.L.M.; Jones, A. Mandatory COVID-19 vaccination and human rights. Lancet 2022, 399, 220–222. [Google Scholar] [CrossRef]
- Graeber, D.; Schmidt-Petri, C.; Schröder, C. Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany. PLoS ONE 2021, 16, e0248372. [Google Scholar] [CrossRef]
- Griffith, J.; Marani, H.; Monkman, H. COVID-19 Vaccine Hesitancy in Canada: Content Analysis of Tweets Using the Theoretical Domains Framework. J. Med. Internet Res. 2021, 23, e26874. [Google Scholar] [CrossRef] [PubMed]
- Rao, A.; Ma, H.; Moloney, G.; Kwong, J.C.; Jüni, P.; Sander, B.; Kustra, R.; Baral, S.D.; Mishra, S. A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada. Ann. Epidemiol. 2021, 63, 63–67. [Google Scholar] [CrossRef] [PubMed]
- Rothbaum, J.; Eggleston, J.; Klee, M.; Mendez-Smith, B. An Overview of Addressing Nonresponse Bias in the American Community Survey During the COVID-19 Pandemic Using Administrative Data. 2021. Available online: https://www.census.gov/newsroom/blogs/random-samplings/2021/11/nonresponse-acs-covid-administrative-data.html (accessed on 6 August 2022).
- Yim, B.; Maklad, K.; Sherazi, S.; Tariq, M.; Usman, M.; Gupta, S. COVID vaccine acceptance in inner-city minority cancer population. J. Clin. Oncol. 2021, 39, 134. [Google Scholar] [CrossRef]
- Papadakos, J.; Reznikov, V.; Giannopoulos, E.; Giuliani, M.; Papadakos, T. The Literacy Demand of Cancer & COVID-19 Consumer Health Information. J. Consum. Health Internet 2021, 25, 50–64. [Google Scholar] [CrossRef]
- Escandón, K.; Rasmussen, A.L.; Bogoch, I.I.; Murray, E.J.; Escandón, K.; Popescu, S.V.; Kindrachuk, J. COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection. BMC Infect Dis. 2021, 21, 710. [Google Scholar] [CrossRef]
- Zeilinger, E.L.; Lubowitzki, S.; Unseld, M.; Schneckenreiter, C.; Heindl, D.; Staber, P.B.; Raderer, M.; Valent, P.; Zöchbauer-Müller, S.; Bartsch, R.; et al. The impact of COVID-19 on cancer care of outpatients with low socioeconomic status. Int. J. Cancer. 2022, 151, 77–82. [Google Scholar] [CrossRef]
- Soni, S.; Tiwari, R.; Pareek, P.; Manna, S.; Sharma, R.; Vyas, R.K.; Devnani, B. Assessment of knowledge, attitude, practices and distress level of cancer patients in COVID-19 pandemic: A cross-sectional study. Cancer Treat. Res. Commun. 2022, 32, 100610. [Google Scholar] [CrossRef]
| Variables | N (%) | 
|---|---|
| Gender | |
| Male | 839 (49) | 
| Female | 861 (51) | 
| Other | 4 (0) | 
| Missing | 56 | 
| Age | |
| Mean (SD) | 61.8 (13.9) | 
| Median (Min, Max) | 64 (19,100) | 
| Missing | 83 | 
| Sexuality | |
| Heterosexual | 1534 (91) | 
| Other | 160 (9) | 
| Missing | 66 | 
| Country of Birth | |
| Canada | 1046 (62) | 
| Other | 654 (38) | 
| Missing | 60 | 
| First Language | |
| English | 1298 (76) | 
| Other | 401 (24) | 
| Missing | 61 | 
| Language Spoken at Home | |
| English | 1452 (86) | 
| Other | 242 (14) | 
| Missing | 66 | 
| Understand Health Information in English | |
| Yes | 1655 (97) | 
| No | 49 (3) | 
| Missing | 56 | 
| Comfort Filling Out Medical Forms | |
| Yes | 1587 (94) | 
| No | 105 (6) | 
| Missing | 68 | 
| Race | |
| White/Caucasian/European | 1296 (76) | 
| Other | 415 (24) | 
| Missing | 49 | 
| Highest Level of Education Completed | |
| Low | 263 (16) | 
| Medium | 1051 (62) | 
| High | 382 (23) | 
| Missing | 64 | 
| Annual Household Income | |
| Less than USD 40,000 | 223 (17) | 
| USD 40,000–59,999 | 173 (13) | 
| USD 60,000–99,999 | 329 (25) | 
| More than USD 100,000 | 589 (45 | 
| Missing | 46 | 
| Main Work-Related Activity | |
| Working (part time or full-time) | 684 (40) | 
| Retired | 20 (1) | 
| Other | 1005 (59) | 
| Missing | 51 | 
| Marital Status | |
| Married/common law | 223 (13) | 
| Other | 1484 (87) | 
| Missing | 53 | 
| Living Arrangements | |
| Alone | 336 (20) | 
| Not alone | 1366 (80) | 
| Missing | 58 | 
| Do you live with someone whose job puts them in contact with others? | |
| Yes | 531 (39) | 
| No | 780 (58) | 
| Not sure | 37 (3 | 
| Missing | 412 | 
| Are you an essential worker? | |
| Yes | 487 (74) | 
| No | 175 (26) | 
| Missing | 1098 | 
| If you live with someone whose job puts them in contact with others, are they vaccinated? | |
| Yes—fully vaccinated | 484 (91) | 
| Yes—partially vaccinated | 15 (3) | 
| No | 16 (3) | 
| Not sure | 15 (3) | 
| Missing | 1230 | 
| Cancer Type | |
| Blood cancer | 308 (19) | 
| Other | 1288 (81) | 
| Missing | 164 | 
| Treatment Stage | |
| In treatment | 281 (17) | 
| Not in treatment | 377 (23) | 
| Follow-up | 1003 (60) | 
| Missing | 99 | 
| How has COVID-19 changed your appointments? | |
| Made virtual | 948 (59) | 
| No change | 667 (41) | 
| Missing | 145 | 
| Variables | N “Yes” | 
|---|---|
| Delayed by less than 2 weeks | |
| No | 1634 (98) | 
| Yes | 27 (2) | 
| Missing | 99 | 
| Delayed by more than two weeks but less than 3 months | |
| No | 1575 (95) | 
| Yes | 86 (5) | 
| Missing | 99 | 
| Delayed by more than 3 months | |
| No | 1641 (99) | 
| Yes | 20 (1) | 
| Missing | 99 | 
| Delayed by more than 3 months but less than 6 months | |
| No | 1642 (99) | 
| Yes | 19 (1) | 
| Missing | 99 | 
| Delayed by more than 6 months | |
| No | 1641 (99) | 
| Yes | 20(1) | 
| Missing | 99 | 
| Delayed and I do not know when it will be rescheduled | |
| No | 1656 (100) | 
| Yes | 5 (0) | 
| Missing | 99 | 
| No change; my treatments were carried out as planned | |
| No | 622 (37) | 
| Yes | 1039 (63) | 
| Missing | 99 | 
| I Am Worried/Afraid That… | N (%) | |||||
|---|---|---|---|---|---|---|
| Strongly Disagree | Disagree | Neutral | Agree | Strongly Agree | Missing | |
| The COVID-19 pandemic and the response to it will make it hard for me to get cancer care in the future. | 267 (16) | 401 (25) | 472 (29) | 367 (23) | 120 (7) | 133 | 
| I will experience complications with my current cancer treatment because of the COVID-19 pandemic. | 66 (21) | 95 (30) | 106 (33) | 35 (11) | 16 (5) | 1442 | 
| My cancer will return and not be detected or managed properly because of the COVID-19 pandemic. | 232 (18) | 386 (30) | 339 (27) | 221 (17) | 89 (7) | 493 | 
| I will get COVID-19 by coming to the cancer centre. | 358 (31) | 440 (38) | 240 (21) | 101 (9) | 31 (3) | 590 | 
| Never/ Very Poor | Rarely/ Poor | Sometimes/ Neutral | Often/ Good/ | Always/ Excellent | Missing | |
|---|---|---|---|---|---|---|
| Television stations | ||||||
| Usage | 156 (10) | 197 (12) | 347 (22) | 508 (32) | 380 (24) | 172 | 
| Quality/trustworthiness | 52 (3) | 130 (9) | 385 (26) | 730 (49) | 192 (13) | 271 | 
| Daily or weekly print newspapers | ||||||
| Usage | 547 (37) | 258 (17) | 279 (19) | 235 (16) | 166 (11) | 275 | 
| Quality/trustworthiness | 41 (4) | 73 (6) | 363 (32) | 533 (47) | 129 (11) | 621 | 
| Websites or online news pages | ||||||
| Usage | 130 (8) | 157 (10) | 459 (29) | 489 (31) | 326 (21) | 199 | 
| Quality/trustworthiness | 50 (3) | 133 (9) | 569 (40) | 585 (41) | 100 (7) | 323 | 
| Public health department and press releases | ||||||
| Usage | 86 (5) | 143 (9) | 460 (29) | 519 (33) | 370 (23) | 182 | 
| Quality/trustworthiness | 26 (2) | 33 (2) | 202 (14) | 694 (47) | 534 (36) | 271 | 
| Conversations with friends and family | ||||||
| Usage | 85 (5) | 302 (19) | 651 (41) | 414 (26) | 145 (9) | 163 | 
| Quality/trustworthiness | 56 (4) | 172 (12) | 761 (52) | 429 (29) | 53 (4) | 289 | 
| Conversations with work colleagues | ||||||
| Usage | 394 (32) | 297 (24) | 344 (28) | 162 (13) | 52 (4) | 511 | 
| Quality/trustworthiness | 85 (9) | 139 (14) | 520 (54) | 189 (20) | 28 (3) | 799 | 
| Journal articles | ||||||
| Usage | 432 (30) | 367 (25) | 446 (31) | 166 (11) | 43 (3) | 306 | 
| Quality/trustworthiness | 31 (3) | 46 (4) | 393 (35) | 452 (40) | 196 (18) | 642 | 
| Social media | ||||||
| Usage | 665 (44) | 305 (20) | 320 (21) | 150 (10) | 86 (6) | 234 | 
| Quality/trustworthiness | 353 (30) | 319 (27) | 323 (28) | 150 (13) | 24 (2) | 591 | 
| Search engines | ||||||
| Usage | 273 (18) | 300 (19) | 578 (37) | 306 (20) | 100 (6) | 203 | 
| Quality/trustworthiness | 86 (6) | 167 (12) | 605 (45) | 443 (33) | 58 (4) | 401 | 
| Radio stations | ||||||
| Usage | 380 (25) | 321 (21) | 468 (31) | 260 (17) | 103 (7) | 228 | 
| Quality/trustworthiness | 63 (5) | 99 (8) | 482 (39) | 501 (40) | 95 (8) | 520 | 
| Cancer centre resources | ||||||
| Usage | 432 (28) | 448 (29) | 437 (28) | 148 (10) | 78 (5) | 217 | 
| Quality/trustworthiness | 20 (2) | 34 (3) | 261 (22) | 476 (41) | 373 (32) | 596 | 
| Question | N (%) | ||||||
|---|---|---|---|---|---|---|---|
| Strongly Disagree | Disagree | Neutral | Agree | Strongly Agree | Does Not Apply | Missing | |
| It has been difficult to focus on tasks because of concerns about COVID-19 | 214 (14) | 487 (31) | 312 (20) | 436 (28) | 104 (7) | 21 (1) | 186 | 
| It has been difficult for me to sleep because of concerns about COVID-19 | 382 (24) | 570 (36) | 331 (21) | 220 (14) | 49 (3) | 25 (2) | 183 | 
| I have had fears about getting COVID-19 | 128 (8) | 256 (16) | 308 (20) | 641 (41) | 223 (14) | 18 (1) | 186 | 
| I have had fears of family/loved ones getting COVID-19 | 62 (4) | 149 (9) | 183 (12) | 778 (49) | 384 (24) | 18 (1) | 186 | 
| I have had fears of friends getting COVID-19 | 78 (5) | 176 (11) | 306 (19) | 785 (50) | 206 (13) | 19 (1) | 190 | 
| I have felt socially isolated from friends and family because of COVID-19 | 75 (5) | 195 (12) | 200 (13) | 657 (42) | 426 (27) | 17 (1) | 190 | 
| I have felt angry and irritable because of COVID-19 | 202 (13) | 388 (25) | 369 (23) | 431 (27) | 162 (10) | 21 (1) | 187 | 
| I have felt anxious about financial concerns because of COVID-19 | 263 (17) | 462 (29) | 311 (20) | 281 (18) | 192 (12) | 64 (4) | 187 | 
| Question | N (%) | |||
|---|---|---|---|---|
| True | False | I Do Not Know | Missing | |
| Symptoms of COVID-19 include fever, fatigue, dry cough, and muscle pain | 1430 (93) | 36 (2) | 71 (5) | 223 | 
| Unlike the common cold, stuffy nose, runny nose, and sneezing are less common in people who have COVID-19. | 573 (37) | 600 (39) | 364 (24) | 223 | 
| Right now, there is no cure for COVID-19, but catching symptoms early and getting treatment can help patients recover from the virus. | 1250 (81) | 166 (11) | 123 (8) | 221 | 
| Not all people with COVID-19 will develop to severe cases. Seniors and people with chronic illnesses are more likely to be severe cases. | 1451 (94) | 51 (3) | 40 (3) | 218 | 
| Eating or touching wild animals can cause you to become sick with the COVID-19 virus. | 87 (6) | 1132 (73) | 322 (21) | 219 | 
| People with COVID-19 cannot give the virus to others when they do not have a fever. | 52 (3) | 1389 (90) | 95 (6) | 224 | 
| The COVID-19 virus spreads via respiratory droplets through coughing, sneezing or intimate contact. | 1493 (97) | 19 (1) | 22 (1) | 226 | 
| Wearing a medical mask can help prevent the COVID-19 virus from spreading. | 1494 (97) | 22 (1) | 25 (2) | 219 | 
| Children and young adults do not have to take measures to prevent the spread of the COVID-19 virus. | 28 (2) | 1480 (96) | 32 (2) | 220 | 
| To prevent the spread of COVID-19, people should limit (stop) going to crowded places and limit taking public transportation. | 1319 (86) | 148 (10) | 73 (5) | 220 | 
| Isolation and treatment of people with COVID-19 are ways to slow down the spread of the virus. | 1474 (96) | 26 (2) | 40 (3) | 220 | 
| People who have contact with someone who has the COVID-19 virus should be isolated in a safe place for at least 14 days. | 1443 (94) | 55 (4) | 44 (3) | 218 | 
| The incubation period of COVID-19 can be up to 14 days. | 1399 (91) | 36 (2) | 106 (7) | 219 | 
| People with cancer have to be more careful than people to protect themselves against COVID-19. | 1394 (90) | 51 (3) | 97 (6) | 218 | 
| Actions | N (%) | |||
|---|---|---|---|---|
| Yes | No | Does Not Apply | Missing | |
| Hand washing for 20 s | 1493 (98) | 32 (2) | 5 (0) | 230 | 
| Did not touch your eyes, nose, and mouth with unwashed hands | 1362 (89) | 159 (10) | 10 (1) | 229 | 
| Used disinfectants to clean your hands | 1496 (98) | 33 (2) | 4 (0) | 227 | 
| Stayed home when you were sick or had a cold | 1153 (75) | 8 (1) | 370 (24) | 229 | 
| Did not go near someone who was sick or had a cold | 1342 (88) | 82 (5) | 106 (7) | 230 | 
| Wore personal protective equipment when leaving home | 1501 (98) | 29 (2) | 2 (0) | 228 | 
| Only made essential trips outside of the home | 1357 (89) | 160 (10) | 16 (1) | 227 | 
| Did not go to crowded places | 1398 (91) | 118 (8) | 15 (1) | 229 | 
| Practiced social distancing as much as possible | 1505 (98) | 22 (1) | 5 (0) | 228 | 
| Self-quarantined | 699 (46) | 312 (20) | 520 (34) | 229 | 
| Question | N (%) | |||||
|---|---|---|---|---|---|---|
| Strongly Agree | Agree | Neutral | Disagree | Strongly Disagree | Missing | |
| Do you think the COVID-19 pandemic can be successfully controlled? | 316 (21) | 889 (59) | 231 (15) | 72 (5) | 0 (0) | 252 | 
| Do you think that Princess Margaret Cancer Centre has done a good job of responding to the COVID-19 pandemic? | 672 (45) | 697 (46) | 127 (8) | 11 (1) | 0 (0) | 253 | 
| As a person affected by cancer, do you feel confident that you know what to do to protect yourself from COVID-19? | 648 (43) | 781 (52) | 70 (5) | 13 (1) | 0 (0) | 248 | 
| Question | N (%) | 
|---|---|
| Do you believe that the COVID-19 vaccines will help control the spread of COVID-19? | |
| Yes | 40 (3) | 
| No | 1407 | 
| I do not know | 59 (4) | 
| Missing | 254 | 
| Have you had at least one dose of the vaccine? | |
| No | 46 (3) | 
| Yes | 1464 (97) | 
| Missing | 250 | 
| If you have not had the vaccine, do you plan on doing so? | |
| No | 23 (51) | 
| Yes | 4 (9) | 
| Undecided | 18 (40) | 
| Missing | 1715 | 
| What is your motivation for getting the vaccine or wanting to get the vaccine? (Select all that apply) | |
| Protect my health | |
| No | 185 (12) | 
| Yes | 1365 (88) | 
| Missing | 210 | 
| Protect health of family/friends | |
| No | 305 (20) | 
| Yes | 1245 (80) | 
| Missing | 210 | 
| Protect health of co-workers | |
| No | 1012 (65) | 
| Yes | 538 (35) | 
| Missing | 210 | 
| Protect health of community | |
| No | 460 (30) | 
| Yes | 1090 (70) | 
| Missing | 210 | 
| To get back to work/school | |
| No | 1188 (77) | 
| Yes | 362 (23) | 
| Missing | 210 | 
| To resume social activities | |
| No | 636 (41) | 
| Yes | 914 (59) | 
| Missing | 210 | 
| To resume travel | |
| No | 780 (50) | 
| Yes | 770 (50) | 
| Missing | 210 | 
| Because others encouraged me to get the vaccine | |
| No | 1443 (93) | 
| Yes | 107 (7) | 
| Missing | 210 | 
| Not sure | |
| No | 1532 (99) | 
| Yes | 18 (1) | 
| Missing | 210 | 
| Question | N (%) | 
|---|---|
| Do you think that you should avoid people from countries where COVID-19 case numbers are/deaths are high (for example Brazil or India)? | |
| Yes | 727 (48) | 
| No | 465 (31) | 
| I do not know | 249 (17) | 
| I prefer not to say | 68 (5) | 
| Missing | 251 | 
| Have you seen, heard, or experienced any incidents of discrimination related to COVID-19? | |
| Yes | 338 (22) | 
| No | 1170 (78) | 
| Missing | 252 | 
| What was your role? | |
| You were the target | 30 (9) | 
| You witnessed it | 137 (41) | 
| You supported someone who experienced it | 64 (19) | 
| Other | 105 (31) | 
| N | Adjusted Estimate (95% CI) | p-Value | Holm Adj p | |
|---|---|---|---|---|
| Model 1. Psychological Impact | ||||
| Ethnicity | 1570 | <0.001 | 0.001 | |
| White | 1208 | Reference | ||
| Other | 362 | 3.30 (1.30, 5.30) | ||
| Use of Journal Articles | 1412 | 0.001 | 0.002 | |
| Never | 416 | Reference | ||
| Rarely | 353 | 2.26 (−6 × 10−3, 4.53) | 0.032 | 0.051 | 
| Sometimes | 436 | 3.65 (1.50, 5.80) | <0.001 | <0.001 | 
| Often | 165 | 4.58 (1.68, 7.47) | 0.001 | 0.002 | 
| Always | 42 | 5.46 (0.39, 10.52) | 0.035 | 0.035 | 
| N | Adjusted Odds Ratio (95% CI) | p-Value | Holm Adj p | |
|---|---|---|---|---|
| Model 1. Vaccine Uptake | ||||
| Age | 1475 | 1.03 (1.00, 1.06) | <0.001 | 0.035 | 
| Income | 1155 | <0.001 | 0.001 | |
| Less than USD 400,00 | 184 | Reference | ||
| USD 40,000–59,999 | 148 | 6.00 (1.26, 28.54) | 0.019 | 0.024 | 
| USD 60,000–99,999 | 296 | 4.48 (1.48, 13.58) | 0.005 | 0.008 | 
| More than USD 100,000 | 527 | 6.52 (2.41, 17.66) | <0.001 | <0.001 | 
| Television stations usage | 1478 | <0.001 | 0.07 | |
| Never | 143 | Reference | ||
| Rarely | 182 | 2.07 (0.51, 8.36) | 0.08 | 0.3 | 
| Sometimes | 323 | 1.04 (0.34, 3.20) | 0.38 | 0.95 | 
| Often | 475 | 3.49 (0.90, 13.62) | 0.004 | 0.072 | 
| Always | 355 | 5.35 (0.96, 29.64) | 0.001 | 0.055 | 
| Public health department and press releases usage | 1467 | <0.001 | 0.038 | |
| Never | 76 | Reference | ||
| Rarely | 134 | 0.79 (0.19, 3.18) | 0.45 | 0.74 | 
| Sometimes | 420 | 3.29 (0.84, 12.94) | 0.005 | 0.088 | 
| Often | 488 | 3.30 (0.83, 13.13) | <0.001 | 0.09 | 
| Always | 349 | 5.17 (0.84, 31.69) | <0.001 | 0.076 | 
| Model 2. I am worried that the COVID-19 pandemic and the response to it will make it hard for me to get cancer care in the future | ||||
| Age | 1590 | 0.99 (0.98, 1.00) | <0.001 | 0.004 | 
| Public health department and press releases usage | 1466 | 0.01 | 0.002 | |
| Never | 25 | Reference | ||
| Rarely | 32 | 1.06 (0.23, 4.79) | 0.82 | 0.94 | 
| Sometimes | 199 | 0.44 (0.14, 1.42) | 0.52 | 0.17 | 
| Often | 683 | 0.33 (0.11, 1.04) | 0.16 | 0.06 | 
| Always | 527 | 0.27 (0.09, 0.85) | 0.11 | 0.03 | 
| Model 3. I fear that my cancer will return and not be detected or managed properly because of the COVID-19 pandemic | ||||
| Age | 1239 | 0.98 (0.98, 0.99) | <0.001 | <0.001 | 
| Public health department and press releases usage | 1151 | |||
| Never | 19 | Reference | ||
| Rarely | 22 | 0.74 (0.21, 2.59) | 0.43 | 0.64 | 
| Sometimes | 159 | 0.54 (0.21, 1.37) | 0.28 | 0.19 | 
| Often | 529 | 0.45 (0.18, 1.09) | 0.09 | 0.08 | 
| Always | 422 | 0.34 (0.14, 0.85) | 0.03 | 0.02 | 
| Model 4. I am afraid of getting COVID-19 by coming to the cancer centre | ||||
| Ethnicity | 1167 | |||
| White | 895 | Reference | <0.001 | 0.03 | 
| Other | 272 | 1.53 (1.05, 2.21) | ||
| Television stations usage | 1124 | 0.002 | 0.04 | |
| Never | 102 | Reference | ||
| Rarely | 132 | 0.63 (0.35, 1.13) | 0.16 | 0.12 | 
| Sometimes | 252 | 0.81 (0.48, 1.37) | 0.91 | 0.44 | 
| Often | 355 | 0.78 (0.47, 1.30) | 1.00 | 0.35 | 
| Always | 283 | 1.24 (0.73, 2.09) | 0.07 | 0.43 | 
| Public health department and press releases usage | 1057 | 0.002 | 0.02 | |
| Never | 16 | Reference | ||
| Rarely | 20 | 3.29 (0.45, 24.26) | 0.003 | 0.24 | 
| Sometimes | 130 | 6.10 (1.07, 34.87) | 0.004 | 0.04 | 
| Often | 493 | 5.26 (0.95, 28.99) | 0.01 | 0.06 | 
| Always | 398 | 3.73 (0.68, 20.57) | 0.03 | 0.13 | 
| Model 5. Daily or weekly print newspapers usage | ||||
| Age | 1553 | 1.02 (1.01, 1.03) | <0.001 | <0.001 | 
| Education | 1572 | <0.001 | <0.001 | |
| Low | Reference | |||
| Medium | 0.75 (0.56, 0.99) | <0.001 | 0.043 | |
| High | 0.54 (0.38, 0.74) | <0.001 | <0.001 | |
| Television stations usage | 1468 | <0.001 | <0.001 | |
| Never | 50 | Reference | ||
| Rarely | 125 | 2.61 (1.28, 5.33) | 0.002 | 0.008 | 
| Sometimes | 379 | 4.56 (2.33, 8.90) | <0.001 | <0.001 | 
| Often | 724 | 14.49 (7.45, 28.20) | <0.001 | <0.001 | 
| Always | 190 | 47.75 (23.11, 98.68) | <0.001 | <0.001 | 
| Age | 1455 | 1.05 (1.04, 1.07) | <0.001 | <0.001 | 
| Education | 1470 | <0.001 | 0.028 | |
| Low | 218 | Reference | ||
| Medium | 907 | 1.38 (0.87, 2.18) | 0.065 | 0.17 | 
| High | 345 | 1.98 (1.17, 3.35) | <0.001 | 0.011 | 
| Daily or weekly print newspapers Perceived Quality | 1085 | <0.001 | <0.001 | |
| Very poor | 37 | Reference | ||
| Poor | 70 | 11.54 (2.28, 58.51) | <0.001 | 0.003 | 
| Neutral | 345 | 20.46 (4.50, 93.01) | <0.001 | <0.001 | 
| Good | 510 | 63.11 (13.88, 286.92) | <0.001 | <0.001 | 
| Excellent | 123 | 228.97 (47.41, 1.1 × 103) | <0.001 | <0.001 | 
| Age | 1529 | 0.98 (0.97, 0.99) | <0.001 | <0.001 | 
| Education | 1546 | <0.001 | <0.001 | |
| Low | 232 | Reference | ||
| Medium | 960 | 1.61 (1.12, 2.31) | <0.001 | 0.01 | 
| High | 354 | 2.28 (1.50, 3.47) | <0.001 | <0.001 | 
| Websites or online news pages usage | 1406 | <0.001 | <0.001 | |
| Never | 47 | Reference | ||
| Rarely | 129 | 3.40 (1.50, 7.67) | <0.001 | 0.003 | 
| Sometimes | 555 | 4.52 (2.14, 9.54) | <0.001 | <0.001 | 
| Often | 575 | 14.34 (6.74, 30.54) | <0.001 | <0.001 | 
| Always | 100 | 34.96 (14.76, 82.77) | <0.001 | <0.001 | 
| Model 6. Public Health Department and Press Releases | ||||
| Public health department and press releases perceived quality | 1462 | <0.001 | <0.001 | |
| Very poor | 25 | Reference | ||
| Poor | 32 | 9.20 (3.13, 27.09) | <0.001 | <0.001 | 
| Neutral | 194 | 11.16 (4.52, 27.55) | <0.001 | <0.001 | 
| Good | 681 | 26.07 (10.66, 63.73) | <0.001 | <0.001 | 
| Excellent | 530 | 68.64 (27.71, 170.06) | <0.001 | <0.001 | 
| Model 7. Conversations with friends and family | ||||
| Language Spoken | 1575 | <0.001 | <0.001 | |
| English | 1362 | Reference | ||
| Other | 213 | 1.82 (1.28, 2.60) | ||
| Conversations with friends and family perceived quality | 1575 | <0.001 | <0.001 | |
| Very poor | 55 | Reference | ||
| Poor | 168 | 5.42 (2.81, 10.44) | <0.001 | <0.001 | 
| Neutral | 758 | 24.89 (13.29, 46.61) | <0.001 | <0.001 | 
| Good | 423 | 95.60 (49.84, 183.38) | <0.001 | <0.001 | 
| Excellent | 53 | 309.87 (135.65, 707.84) | <0.001 | <0.001 | 
| Model 8. Conversations with work colleagues | ||||
| Employment | 1244 | <0.001 | <0.001 | |
| Working (part-time or full-time) | 618 | Reference | ||
| Retired | 16 | 5.80 (1.73, 19.40) | 0.025 | 0.004 | 
| Other | 610 | 0.33 (0.24, 0.46) | <0.001 | <0.001 | 
| Q16 Contact Others | 994 | <0.001 | 0.029 | |
| No | 546 | Reference | ||
| Yes | 422 | 1.46 (1.09, 1.95) | <0.001 | 0.01 | 
| Not sure | 26 | 0.93 (0.42, 2.06) | 0.006 | 0.86 | 
| Conversations with work colleagues perceived quality | 925 | <0.001 | <0.001 | |
| Very poor | 84 | Reference | ||
| Poor | 135 | 5.57 (2.89, 10.76) | <0.001 | <0.001 | 
| Neutral | 500 | 15.10 (8.25, 27.64) | <0.001 | <0.001 | 
| Good | 178 | 90.14 (45.21, 179.72) | <0.001 | <0.001 | 
| Excellent | 28 | 395.60 (136.54, 1.1 × 103) | <0.001 | <0.001 | 
| Model 9. Social Media usage | ||||
| Age | 1494 | 0.96 (0.95, 0.98) | <0.001 | <0.001 | 
| Social media perceived quality | 1143 | <0.001 | <0.001 | |
| Very poor | 344 | Reference | ||
| Poor | 315 | 8.19 (5.36, 12.50) | <0.001 | <0.001 | 
| Neutral | 313 | 21.54 (13.49, 34.40) | <0.001 | <0.001 | 
| Good | 148 | 100.90 (55.71, 182.74) | <0.001 | <0.001 | 
| Excellent | 23 | 479.18 (142.20, 1.6 × 103) | <0.001 | <0.001 | 
| Model 10. Search engine usage | ||||
| Age | 1525 | 0.98 (0.97, 0.99) | <0.001 | <0.001 | 
| Country Born | 1540 | <0.001 | 0.004 | |
| Canada | 977 | Reference | ||
| Other | 563 | 1.43 (1.12, 1.84) | ||
| Search engines perceived quality | 1342 | <0.001 | <0.001 | |
| Very poor | 82 | Reference | ||
| Poor | 164 | 8.02 (4.54, 14.16) | <0.001 | <0.001 | 
| Neutral | 598 | 26.65 (15.68, 45.29) | <0.001 | <0.001 | 
| Good | 440 | 108.02 (61.89, 188.51) | <0.001 | <0.001 | 
| Excellent | 58 | 215.48 (101.66, 456.71) | <0.001 | <0.001 | 
| Model 11. Radio Station usage | ||||
| Radio stations perceived quality | 1209 | <0.001 | <0.001 | |
| Very poor | 60 | Reference | ||
| Poor | 95 | 2.73 (1.44, 5.18) | 0.002 | 0.002 | 
| Neutral | 471 | 8.96 (5.06, 15.86) | <0.001 | <0.001 | 
| Good | 489 | 36.86 (20.51, 66.26) | <0.001 | <0.001 | 
| Excellent | 94 | 174.18 (86.79, 349.56) | <0.001 | <0.001 | 
| Model 12. Cancer Centre resources usage | ||||
| Cancer centre resources perceived quality | 1140 | <0.001 | <0.001 | |
| Very poor | 18 | Reference | ||
| Poor | 33 | 6.79 (1.69, 27.25) | 0.008 | 0.007 | 
| Neutral | 255 | 13.33 (3.79, 46.93) | <0.001 | <0.001 | 
| Good | 466 | 39.57 (11.28, 138.83) | <0.001 | <0.001 | 
| Excellent | 368 | 67.36 (19.06, 238.07) | <0.001 | <0.001 | 
| Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. | 
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ugas, M.A.; Avery, L.; Wang, Y.; Berlin, A.; Giuliani, M.E.; Krzyzanowska, M.; Papadakos, T.J.; Quartey, N.K.; Samoil, D.; Papadakos, J.K. COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices. Curr. Oncol. 2022, 29, 8917-8936. https://doi.org/10.3390/curroncol29110701
Ugas MA, Avery L, Wang Y, Berlin A, Giuliani ME, Krzyzanowska M, Papadakos TJ, Quartey NK, Samoil D, Papadakos JK. COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices. Current Oncology. 2022; 29(11):8917-8936. https://doi.org/10.3390/curroncol29110701
Chicago/Turabian StyleUgas, Mohamed A., Lisa Avery, Yanning Wang, Alejandro Berlin, Meredith E. Giuliani, Monika Krzyzanowska, Tina J. Papadakos, Naa Kwarley (Linda) Quartey, Diana Samoil, and Janet K. Papadakos. 2022. "COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices" Current Oncology 29, no. 11: 8917-8936. https://doi.org/10.3390/curroncol29110701
APA StyleUgas, M. A., Avery, L., Wang, Y., Berlin, A., Giuliani, M. E., Krzyzanowska, M., Papadakos, T. J., Quartey, N. K., Samoil, D., & Papadakos, J. K. (2022). COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices. Current Oncology, 29(11), 8917-8936. https://doi.org/10.3390/curroncol29110701
 
        

 
       